Etiological Factors and Clinical Outcomes of Acute Hyperkalemia Among Hospitalized Patients at a Tertiary Care Hospital in Peshawar
DOI:
https://doi.org/10.52206/jsmc.2026.16.1.1237Abstract
Background: Acute hyperkalemia is a potentially life-threatening electrolyte imbalance frequently encountered among hospitalized patients, particularly those with renal dysfunction and multiple comorbidities. It is associated with serious cardiac complications and increased morbidity and mortality. Understanding the underlying etiological factors and clinical outcomes is essential for timely diagnosis, appropriate management, and improved patient care.
Objective: To determine the frequency, etiological factors, management strategies, and clinical outcomes of acute hyperkalemia among hospitalized patients at a tertiary care hospital in Peshawar.
Methodology: This descriptive cross-sectional study was conducted in the Department of Nephrology, Northwest General Hospital and Research Centre, Peshawar, Pakistan, from September 2020 to June 2024. A total of 142 hospitalized patients with serum potassium levels >5.0 mEq/L were included using non-probability consecutive sampling. Data on demographic characteristics, clinical presentation, comorbidities, medication history, laboratory parameters, treatment modalities, and clinical outcomes were collected using a structured proforma. Hyperkalemia was classified as mild, moderate, or severe.
Results: The median age of patients was 60 years (IQR = 19), with females comprising 54.9% of the cohort. Hypertension (59.9%), diabetes mellitus (48.6%), and chronic kidney disease (45.8%) were the most common comorbidities. Acute kidney injury was present in 49.3% of patients. Medications frequently associated with hyperkalemia included angiotensin-converting enzyme inhibitors (43.7%), diuretics (27.5%), and nonsteroidal anti-inflammatory drugs (23.9%). Severe hyperkalemia (>6.5 mEq/L) was observed in 47.2% of patients. Intravenous calcium (81%) and insulin-dextrose infusion (67.6%) were the most commonly used treatments. Potassium normalization was achieved in 41.5% of patients. Significant associations with potassium normalization were observed for nebulized salbutamol (p = 0.043) and intravenous bicarbonate (p = 0.016). Overall, 95.8% of patients were discharged in stable condition, while the in-hospital mortality rate was 4.2%.
Conclusion: Acute hyperkalemia among hospitalized patients was commonly associated with multiple comorbidities and the use of potassium-altering medications, particularly ACE inhibitors and NSAIDs. Despite standard management, potassium normalization was achieved in less than half of patients, highlighting the need for individualized treatment strategies, vigilant monitoring, and early intervention to improve clinical outcomes.
Keywords: Acute Hyperkalemia, Acute Kidney Injury, Clinical Outcomes, Electrolyte Imbalance, Potassium-Altering Medications.
References
Simon LV, Hashmi MF, Farrell MW, Chapagain R. Hyperkalemia (nursing).
Humphrey T, Davids MR, Chothia MY, Pecoits-Filho R, Pollock C, James G. How common is hyperkalemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalemia reported in observational studies. Clin Kidney J. 2022 Apr;15(4):727-37. https://doi.org/10.1093/ckj/sfab243
Memon A, Ali U, Kumar R, Jamali S. Frequency of hyperkalemia in patients presenting with heart failure with reduced ejection fraction at tertiary care hospital Karachi. J Health Rehabil Res. 2024 Jun 26;4(2):1682-6. https://doi.org/10.61919/jhrr.v4i2.838
Logan Ellis H, Al-Agil M, Kelly PA, Teo J, Sharpe C, Whyte MB. The burden of hyperkalaemia on hospital healthcare resources. Clin Exp Med. 2024 Aug 13;24(1):190. https://doi.org/10.1007/s10238-024-01452-7
Qadir A, Ullah Z, Khalil MD, Saqib MN, Khan A, Khan A. Frequency of hyperkalaemia in non-dialysis dependent chronic kidney disease (CKD) patients. Med Forum Mon. 2023 Jun 30;34(6):2-5. https://doi.org/10.60110/230601
Ramesh B, Felix RJ, Viggeswarpu S, Belavendra A. Outcomes in older inpatients with hyperkalemia: A follow-up observational study. J Indian Acad Geriatr. 2024 Apr 1;20(2):70-4. https://doi.org/10.4103/jiag.jiag_14_24
Sevamontree C, Jintajirapan S, Phakdeekitcharoen P, Phakdeekitcharoen B. The prevalence and risk factors of hyperkalemia in the outpatient setting. Int J Nephrol. 2024;2024(1):5694131. https://doi.org/10.1155/2024/5694131
Khan RA, Khan ZA, Ghani A. Demographics and clinical outcomes of hyperkalemia in hospitalized patients: A detailed examination. Pak J Urol. 2024 Aug 10;2(1):92-8. https://doi.org/10.69885/pju.v2i01.54
Ashraf H, Khurram F, Ashraf F. Efficacy, safety, and patient outcomes of emergency treatment with IV insulin-dextrose in patients with hyperkalemia. Biol Clin Sci Res J. 2024;2024(1):991. https://doi.org/10.54112/bcsrj.v2024i1.991
Álvarez-Rodríguez E, Olaizola Mendibil A, San Martín Díez MLÁ, Burzako Sánchez A, Esteban-Fernández A, Sánchez Álvarez E. Recommendations for the management of hyperkalemia in the emergency department. Emergencias. 2022 Aug;34(4):287-97. PMID: 35833768.
Freeze TA, Skerry L, Kervin E, Nunn R, Woodland J, Hanson N, et al. Treatment of mild hyperkalemia in hospitalized patients: An unnecessary practice? Can J Hosp Pharm. 2021;74(3):269. https://doi.org/10.4212/cjhp.v74i3.3154
Butterhoff MH, Derijks HJ, Hermens W, van der Linden PD. Sulfamethoxazole-trimethoprim-induced hyperkalemia in hospitalized patients using potassium-sparing drugs: An observational study. Senior Care Pharm. 2024 Jul 1;39(7):259-66. https://doi.org/10.4140/tcp.n.2024.259
Kanda E, Kashihara N, Kohsaka S, Okami S, Yajima T. Clinical and economic burden of hyperkalemia: A nationwide hospital-based cohort study in Japan. Kidney Med. 2020 Nov 1;2(6):742-52. https://doi.org/10.1016/j.xkme.2020.09.003
Ramesh B, Felix RJ, Viggeswarpu S, Belavendra A. Outcomes in older inpatients with hyperkalemia: A follow-up observational study. J Indian Acad Geriatr. 2024 Apr 1;20(2):70-4. https://doi.org/10.4103/jiag.jiag_14_24
Nilsson E, Gasparini A, Ärnlöv J, Xu H, Henriksson KM, Coresh J, et al. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system. Int J Cardiol. 2017 Oct 15;245:277-84. https://doi.org/10.1016/j.ijcard.2017.07.035
Ramesh B, Felix RJ, Viggeswarpu S, Belavendra A. Outcomes in older inpatients with hyperkalemia: A follow-up observational study. J Indian Acad Geriatr. 2024 Apr 1;20(2):70-4. https://doi.org/10.4103/jiag.jiag_14_24
Valdivielso JM, Carriazo S, Martin M, Fernandez-Fernandez B, Bermudez-López M, Ortiz A. Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: Smoking as a driver of hyperkalemia in men. Clin Kidney J. 2024 Jan;17(1):sfad212. https://doi.org/10.1093/ckj/sfad212
Dai D, Sharma A, Alvarez PJ, Woods SD. Multiple comorbid conditions and healthcare resource utilization among adult patients with hyperkalemia: A retrospective observational cohort study using association rule mining. J Multimorb Comorb. 2022 Apr 28;12:26335565221098832. https://doi.org/10.1177/26335565221098832
Sevamontree C, Jintajirapan S, Phakdeekitcharoen P, Phakdeekitcharoen B. The prevalence and risk factors of hyperkalemia in the outpatient setting. Int J Nephrol. 2024;2024(1):5694131. https://doi.org/10.1155/2024/5694131
Watanabe R. Hyperkalemia in chronic kidney disease. Rev Assoc Med Bras. 2020 Jan 13;66(S1):31-6. https://doi.org/10.1590/1806-9282.66.s1.31
Ravioli S, Pluess E, Funk GC, Walter P, Schwarz C, Exadaktylos AK, et al. Dyskalemias in patients with acute kidney injury presenting to the emergency department are common and independent predictors of adverse outcome. Int J Clin Pract. 2021 Jan;75(1):e13653. https://doi.org/10.1111/ijcp.13653
Bianchi S, Rossi GM. Predicting hyperkalemia in patients with acute kidney injury: Time for a change of weaponry. Intern Emerg Med. 2020 Apr;15:371-2. https://doi.org/10.1007/s11739-019-02245-7
De Nicola L, Ferraro PM, Montagnani A, Pontremoli R, Dentali F, Sesti G. Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors. Intern Emerg Med. 2024 Mar;19(2):295-306. https://doi.org/10.1007/s11739-023-03427-0
Wu Y, Fu Y, Tang H, Lei M, Hao W, Zhu H, et al. [Treatment and factors associated with prognosis of hyperkalemia in the emergency department]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):321-5. Chinese. PMID: 36916348.
Sinnathamby ES, Banh KT, Barham WT, Hernandez TD, De Witt AJ, Wenger DM, et al. Hyperkalemia: Pharmacotherapies and clinical considerations. Cureus. 2024 Jan;16(1). https://doi.org/10.7759/cureus.52994
Piktel JS, Wan X, Kouk S, Laurita KR, Wilson LD. Beneficial effect of calcium treatment for hyperkalemia is not due to "membrane stabilization". Crit Care Med. 2024 Oct 1;52(10):1499-508. https://doi.org/10.1097/CCM.0000000000006376
Pathman DG, Qin X. Calcium showdown: Gluconate vs. chloride in saving lives from cardiac arrest due to hyperkalemia–An in-depth meta-analysis.
Palmer BF, Clegg DJ. Hyperkalemia treatment standard. Nephrol Dial Transplant. 2024 Jul;39(7):1097-104. https://doi.org/10.1093/ndt/gfae056
Mohamed SA. Settings for hyperkalemic patients in emergency department: A prospective study. Int J Health Sci. 6(S8):2681-9. https://doi.org/10.53730/ijhs.v6nS8.12547
Trigonis RA, Ellender TJ. Electrolyte emergencies. In: Emergency Medicine. 2023:295-302. https://doi.org/10.1093/med/9780190082581.003.0031
Montassier E, Lemoine L, Hardouin JB, Rossignol P, Legrand M. Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalemia in the emergency room: Protocol for a randomised, multicentre, controlled study (INSAKA). BMJ Open. 2020 Aug 1;10(8):e039277. https://doi.org/10.1136/bmjopen-2020-039277
Riccio E, Capuano I, Buonanno P, Andreucci M, Provenzano M, Amicone M, et al. RAAS inhibitor prescription and hyperkalemia event in patients with chronic kidney disease: A single-center retrospective study. Front Cardiovasc Med. 2022 Feb 11;9:824095. https://doi.org/10.3389/fcvm.2022.824095
Bakolia SK, Verma GK, Barolia DK. The effect of nebulized salbutamol on serum potassium and blood sugar level of asthmatic patients. Int J Med Biomed Stud. 2021;5(9):154-6. https://doi.org/10.32553/ijmbs.v5i9.2205
Kim HJ. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients. J Korean Med Sci. 1997 Apr;12(2):111-6. https://doi.org/10.3346/jkms.1997.12.2.111
Yagi K, Fujii T, Vincent JL. Management of acute metabolic acidosis in the ICU: Sodium bicarbonate and renal replacement therapy. In: Annual Update in Intensive Care and Emergency Medicine. Cham, Switzerland: Springer International Publishing. 2021:223-31. https://doi.org/10.1186/s13054-021-03677-4
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
